Literature DB >> 28025114

Differences in hippocampal serotonergic activity in a mouse single prolonged stress paradigm impact discriminant fear acquisition and retention.

Deane E Aikins1, John A Strader2, Robert J Kohler2, Nina Bihani2, Shane A Perrine3.   

Abstract

A mouse model of traumatic stress provided insight into a mechanism of individual differences in conditioned fear responding. Hippocampal serotonergic activity (metabolic turnover) was associated with increased behavioral freezing during fear acquisition in a portion of trauma-exposed subjects. These subjects later displayed enhanced fear to the neutral cue during retention. An inability to discriminate fear responses may underlie dysfunctional fear memories in a sub-population of individuals with Posttraumatic Stress Disorder, with contributions from the hippocampal serotonin system.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fear conditioning; Hippocampus; PTSD

Mesh:

Year:  2016        PMID: 28025114     DOI: 10.1016/j.neulet.2016.12.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Systematic Review and Methodological Considerations for the Use of Single Prolonged Stress and Fear Extinction Retention in Rodents.

Authors:  Chantelle Ferland-Beckham; Lauren E Chaby; Nikolaos P Daskalakis; Dayan Knox; Israel Liberzon; Miranda M Lim; Christa McIntyre; Shane A Perrine; Victoria B Risbrough; Esther L Sabban; Andreas Jeromin; Magali Haas
Journal:  Front Behav Neurosci       Date:  2021-05-14       Impact factor: 3.558

2.  Gait and Conditioned Fear Impairments in a Mouse Model of Comorbid TBI and PTSD.

Authors:  Peyton Teutsch; Carolyn E Jones; Mara E Kaiser; Natasha Avalon Gardner; Miranda M Lim
Journal:  Behav Neurol       Date:  2018-09-20       Impact factor: 3.342

Review 3.  Single-Prolonged Stress: A Review of Two Decades of Progress in a Rodent Model of Post-traumatic Stress Disorder.

Authors:  Michael J Lisieski; Andrew L Eagle; Alana C Conti; Israel Liberzon; Shane A Perrine
Journal:  Front Psychiatry       Date:  2018-05-15       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.